It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

The rise in obesity rates across the United States has brought increased attention to treatments aimed at addressing the ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.

Millions more senior citizens and lower-income Americans could obtain coverage for costly anti-obesity drugs under a proposal ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

U.S. President Joe Biden on Tuesday proposed expanding coverage of anti-obesity drugs, like Novo Nordisk's Wegovy, for more ...

The proposed rule could give millions of Americans access to the new drugs; it will also put pressure on the incoming Trump administration.

Medicare and Medicaid recipients with obesity would have access to coverage of pricey GLP-1 receptor agonists like ...

Medicare coverage would reduce out-of-pocket costs for AOMs – which can currently be as high as $1,000 a month - by as much ...

The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid.

The Biden administration has proposed a new rule to “significantly” expand coverage of anti-obesity medications for Americans ...